RUTH TROCHEZ-GALLEGO: Open Payments
NPI 1700510674 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $450 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $433 |
| Novo Nordisk Inc | 7 | $320 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $135 |
| Kowa Pharmaceuticals America, Inc. | 1 | $119 |
| Abbott Laboratories | 1 | $106 |
| ABBVIE INC. | 3 | $54 |
| Verona Pharma, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Lilly USA, LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $21 |
Products named: AIRSUPRA, Ozempic, Kerendia, ZORYVE, BREZTRI, Wegovy, FREESTYLE LIBRE 3, Ohtuvayre.
Industry payments across TX — which companies pay providers there.
